最新ニュース Okta (NASDAQ:OKTA) 株価情報

Okta

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Okta Inc

OKTA CL A ORD

News

Contracts

WFRD

Weatherford Announces Three-Year Contract with ADNOC, Financial Terms Not Disclosed

CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) is looking for FY2024 Adj EPS of $1.67-1.73 vs $1.64 analyst estimate. sees sales of $885.000 million-905.000 million vs $883.61 million estimate.

Guidance

CARG

CarGurus Sees FY2024 Adj EPS $1.67-1.73 vs $1.64 Est; Sees Sales $885.000M-905.000M vs $883.61M Est

Highlighting Tumor-Targeted T Cell Activation and CD40 Modulation in Solid Tumors at SITC 2024

Biotech

General

MOLN

Molecular Partners Unveils Preclinical Proof-Of-Concept For CD3 Switch-DARPin T Cell Engager And Clinical Biomarker Insights For MP0317

Sprout Social Sees Q4 Revenue $106.3M-$107.1M; Q4 Adj. EPS $0.15-$0.16.

Ameresco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) affirms FY2024 Adj EPS guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 analyst estimate. Affirms FY2024 sales outlook from $1.70 billion-1.80 billion to $1.70 billion-1.80 billion vs $1.74 billion estimate.

AMRC

Ameresco Affirms FY2024 Adj EPS Guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 Est; Affirms FY2024 Sales Guidance from $1.70B-1.80B to $1.70B-1.80B vs $1.74B Est

Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.49) by 77.55 percent. This is a 69.44 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $88.83 million which beat the analyst consensus estimate of $84.14 million by 5.58 percent. This is a 5.80 percent increase over sales of $83.97 million the same period last year.

Earnings

Earnings Beats

INGN

Inogen Q3 Adj $(0.11) Beats $(0.49) Estimate, Sales $88.83M Beat $84.14M Estimate

CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) is looking for Q4 Adj EPS of $0.50-0.55 vs $0.46 analyst estimate. sees sales of $219.000 million-239.000 million vs $225.58 million estimate.

CarGurus Sees Q4 Adj EPS $0.50-0.55 vs $0.46 Est; Sees Sales $219.000M-239.000M vs $225.58M Est

W&T Offshore Sees FY24 Total Equivalents (MBoe) 11,900 – 13,267

W&T Offshore Sees Q4 Total Equivalents (MBoe) 2,927-3,253

IONQ

IonQ Partners With imec To Enhance Quantum Computing Scale And Performance Using Photonic Integrated Circuits, Aiming To Increase Qubit Count, Improve System Efficiency, And Reduce Costs For Next-Gen Quantum Computers

Sprout Social Sees FY24 Revenue $405.1M-$405.9M Vs $405.535M Est; FY24 Adj. EPS $0.46-$0.47 Vs $0.46 Est.

FY2025 Guidance
&nbsp;
<ul>
<li>The Company is providing preliminary FY2025 guidance of $12.00 Adjusted Net Income per Diluted Share with the expectation of being a full corporate taxpayer throughout the year (20%-25% effective tax rate).</li>
</ul>

SEZL

Sezzle Is Providing Preliminary FY25 Guidance Of $12.00 Adjusted Net Income Per Diluted Share With The Expectation Of Being A Full Corporate Taxpayer Throughout The Year (20%-25% Effective Tax Rate) Vs $10.09 Est.

SEMR

SEMrush Sees Q4 Total Revenue $100.8M-$101.8M vs $101.03M Est., Sees FY24 Total Revenue $375M-$376M vs $374.45M Est.

Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b41823717/block-announces-third-quarter-2024-results">details from the report.&nbsp;</a>
The Details:&nbsp;Block reported quarterly earnings of 88 cents per share, which beat the analyst consensus estimate of 87 cents. Quarterly revenue came in at $5.97 billion which missed the analyst consensus estimate of $6.24 billion and is an increase over sales of $5.617 billion from the same period last year.
<ul>
<li>Square generated a gross profit of $932 million, up 16% year-over-year.</li>
<li>Cash App generated a gross profit of $1.31 billion, up 21% year-over-year.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
&#8220;We outperformed our gross profit and profitability guidance in the third quarter of 2024. Gross profit grew 19% year over year to $2.25 billion. Cash App continued its strong performance with gross profit growth of 21% year over year, driven primarily by growth in inflows per active and an increase in monetization rate,&#8221; Block wrote in a letter to shareholders.
&#8220;There was strong performance across Cash App Card, Cash App Borrow and our BNPL platform. Square gross profit grew 16% year over year in the third quarter, in line with our expectations, behind strength in our software and integrated payments and banking products,&#8221; the company added.
SQ Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Block shares are down 7.69% after-hours at $69.25 at the time of publication Thursday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

After-Hours Center

Movers

Block Shares Sink After Mixed Q3 Results: EPS Beat, Revenues Miss

nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) sees Q4 sales of $49.000 million-54.000 million vs $59.88 million estimate.

LASR

nLight Sees Q4 Sales $49.000M-54.000M vs $59.88M Est

Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. The company reported quarterly sales of $65.200 million which missed the analyst consensus estimate of $67.555 million by 3.49 percent. This is a 2.49 percent decrease over sales of $66.865 million the same period last year.

Earnings Misses

MRVI

Maravai LifeSciences Q3 2024 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $65.200M Miss $67.555M Estimate

Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) System-wide sales are expected to be between $525 million and $535 million.

JYNT

Joint Corp. FY 2024 System-wide sales are expected to be between $525 million and $535 million.

Updated FY2024 Guidance
&nbsp;
<ul>
<li>The Company is raising several components of its FY2024 guidance due to: 1) continued sustained growth, and 2) the inclusion of the newly launched banking program with WebBank, which was not accounted for in previous guidance.</li>
<li>&nbsp;
<ul>
<li>Net Income: $71.5 million versus $55.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Net Income per Diluted Share: $12.05 versus $9.25 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Growth: 55% versus 35%-40% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Less Transaction Related Costs as a percentage of Total Revenue: No change to the 55% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>Additionally, updating the FY2024 guidance for the following metrics that adjust for certain significant gains, losses, and charges that may not directly correlate to the underlying performance of the Company's business:</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income<a href="http:/#_ftn2">[2]</a>: $58.0 million versus $40.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income per Diluted Share2: $9.80 versus $6.75 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>The Company expects a mid-single digit annualized effective tax before consideration of discrete tax items for 4Q24.</li>
</ul>

Sezzle Increases FY24 Revenue Growth Guidance From 35%-40% To 55%; Adj. Net Income Per Diluted Share From $6.75 To $9.80 Vs $6.73 Est.; Adj. Net Income From $40M To $58M

FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) lowers FY2024 sales outlook from $545.65 million-556.56 million to $540.19 million-545.65 million.

FIGS

FIGS Lowers FY2024 Sales Guidance from $545.65M-556.56M to $540.19M-545.65M

ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.79) by 26.58 percent.

ALXO

ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58) Beats $(0.79) Estimate

Analyst Kingsley Crane of Canaccord Genuity maintained a Hold rating on Okta (OKTA – Research Report), reducing the price target to $82.00. Kingsle...

Okta's Hold Rating: Balancing Security Investments and Market Challenges

Okta in spotlight as Canaccord Genuity cuts price target after Oktane conference

Okta (OKTA) Chairman Todd McKinnon disclosed the sale of 224,533 shares of company stock at $74.62 per share on October 18, for a total transaction...

Okta Chairman Todd McKinnon sells $17M in company shares

White Brook Capital Partners Q3 2024 Commentary

In a report released today, Fatima Boolani from Citi reiterated a Hold rating on Okta (OKTA – Research Report). The company's shares closed last Fr...

Okta (OKTA) Gets a Hold from Citi

A 55-year journey: From the internet's birth to Google, AMZN & META alone worth $5T

Morgan Stanley lowered the firm's price target on Okta (OKTA) to $92 from $100 and keeps an Equal Weight rating on the shares after Okta announced ...

Okta price target lowered to $92 from $100 at Morgan Stanley

Okta (OKTA) announced that on October 30, a vulnerability was internally identified in generating the cache key for AD/LDAP DelAuth. The company sa...

Okta reveals login vulnerability allowing login without password

Okta: Market Ignores Inflection On GAAP Profitability (Ratings Upgrade)

Qualys surges on strong quarter, but will results continue?

AFYA

AKAM

AMZN

APLD

BABA

BKNG

BLDR

BLZE

CHKP

CRWD

CXDO

CYBR

DNUT

DOCN

FTEC

FTNT

GDDY

GOOG

GOOGL

GPRE

NFLX

OKTA

PANW

PETQ

QLYS

RSPC

RSPT

SQQQ

TCEHY

TCTZF

TQQQ

TWLO

UBER

Press Releases

Okta Announces Finalists for SaaS Startup Competition to Build Identity Security Applications

Okta to Host Investor Summit Webcast in Conjunction with Oktane

Okta Helps Builders Easily Implement Auth For GenAI Apps & Secure How Consumers Interact with GenAI Agents

Okta, OpenID Foundation & Tech Firms Tackle Today's Biggest Cybersecurity Challenge: Identity Security in SaaS Apps

Okta is Reducing the Risk of Unmanaged Identities, Social Engineering, and MFA Overload for Enterprise Employees

Opinion

1 Billion Records Stolen in 2024: How Cutting-Edge Tech Is Fighting Back Against Cybercrime

NetHope and Okta: Securing Digital Protection and Cybersecurity for Nonprofits Worldwide

One Third of Canadian SMBs Unaware of the Financial Impact of Cyberattacks Despite Facing Fallout, Okta Survey Finds

NetHope Announces the Launch of the Partner Collective for the Global Humanitarian ISAC at the 2024 NetHope Global Summit

Okta to Announce Third Quarter Fiscal Year 2025 Financial Results on December 3, 2024

Comments

Okta

ニュース

最新ニュース Okta (NASDAQ:OKTA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル